A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 5, 2009, Pages 456-473

  Louboutin, Jean Pierre ^a,b   Agrawal, Lokesh ^a   Reyes, Beverly A S ^b   Van Bockstaele, Elisabeth J ^b   Strayer, David S ^a  

^a Cellular Biology and Anatomy   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Brain; Gp120; HIV dementia; HIV 1; SV40

Indexed keywords

4 HYDROXYNONENAL; ADENOVIRUS VECTOR; ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; GLYCOPROTEIN GP 120; MALONALDEHYDE; 4',6 DIAMIDINO 2 PHENYLINDOLE; 4-HYDROXY-2-NONENAL; AIF1 PROTEIN, HUMAN; ALDEHYDE; DIAGNOSTIC AGENT; DNA BINDING PROTEIN; ENOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; INDOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN; BRAIN DAMAGE; CAUDATE NUCLEUS; CELL DEATH; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 ENCEPHALOPATHY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LIPID PEROXIDATION; NERVE CELL; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RODENT; SIMIAN VIRUS 40; STEREOTAXIS; VIRUS RECOMBINANT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NICK END LABELING; NONPARAMETRIC TEST; NUDE RAT; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; PUTAMEN; SIMIAN VIRUS; SPRAGUE DAWLEY RAT; TIME; VIROLOGY;

ADENOVIRUSES, SIMIAN; AIDS DEMENTIA COMPLEX; ALDEHYDES; ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE PEROXIDASE; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IN SITU NICK-END LABELING; INDOLES; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PUTAMEN; RATS; RATS, NUDE; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 70149098392     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181a10f83     Document Type: Article

References (78)

1. Major EO, Rausch D, Marra C, et al. HIV-associated dementia. Science 2000;288:440-442
2. Mattson MP, Haughey NJ, Nath A. Cell death in HIV dementia. Cell Death Differ 2005;12:893-904
3. Hult B, Chana G, Masliah E, Everall I. Neurobiology of HIV. Int Rev Psychiatry 2008;20:3-13
4. van de Bovenkamp M, Nottet HS, Pereira CF. Interactions of human immunodeficiency virus-1 proteins with neurons: Possible role in the development of human immunodeficiency virus-1 associated dementia. Eur J Clin Invest 2002;32:619-627
5. Regulier EG, Reiss K, Khalili K, et al. T-cells and neuronal apoptosis in HIV infection: Implications for therapeutic intervention. Int Rev Immunol 2004;23:25-59
6. Nath A. Human deficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 2002;186(Suppl 2):S193-98
7. Hurtrel M, Ganiere JP, Guelfi JF, et al. Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS 1992;6:399-406
8. Meeker RB. Feline immunodeficiency virus neurotropism: From cats to calcium. J Neuroimmune Pharmacol 2007;2:154-170
9. Thormar H. Maedi-Visna virus and its relationship to human deficiency virus. AIDS Rev 2005;7:233-245
10. Lackner AA, Veazey RS. Current concepts in AIDS pathogenesis: Insights from the SIV/macaque model. Annu Rev Med 2007;58:461-476
11. Hurtrel B, Chakrabarti L, Hurtrel M, et al. Early SIV encephalopathy. J Med Primatol 1991;20:159-166
12. Zink MC, Clements JE. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J Neurovirol 2002;8(Suppl 2):42-48
13. Sopper S, Koutsilieri E, Scheller C, et al. Macaque animal model for HIV-induced neurological disease. J Neural Transm 2002;109:747-766
14. Toggas SM, Masliah E, Rockenstein EM, et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994;367:188-193
15. Avgeropoulos N, Kelley B, Middaugh L, et al. SCID mice with HIV encephalitis develop behavioral abnormalities. J Acquir Immune Defic Syndr 1998;18:13-20
16. Persidsky Y, Gendelman HE. Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia. J Leukoc Biol 1997;62:100-106
17. Anderson ER, Boyle J, Zink WE, et al. Hippocampal synaptic dysfunction in a murine model of immunodeficiency virus type 1 encephalitis. Neuroscience 2003;118:359-369
18. Miura Y, Misawa N, Kawano Y, et al. Tumor necrosis factorYrelated apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc Natl Acad Sci U S A 2003; 100:2777-2782
19. Griffin WC, Middaugh LD, Cook JD, et al. The severe combined immunodeficient (SCID) mouse model of human immunodeficiency virus encephalitis: Defects in cognitive function. J Neurovirol 2004;10: 109-115
20. Potash MJ, Chao W, Bentsman G, et al. A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuro-invasiveness. Proc Natl Acad Sci U S A 2005;102:3760-3765
21. Agrawal L, Louboutin JP, Reyes BAS, et al. Antioxidant enzyme gene delivery to protect from HIV-1 gp120Yinduced neuronal apoptosis. Gene Ther 2006;13:1645-1656
22. Agrawal L, Louboutin JP, Strayer DS. Preventing HIV-1 TatYinduced apoptosis using antioxidant enzymes: Mechanistic and therapeutic implications. Virology 2007;363:462-472
23. Louboutin JP, Agrawal L, Reyes BAS, et al. Protecting neurons from HIV-1 gp120Yinduced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors. Gene Ther 2007;14:1650-1661
24. Bansal AK, Mactutus CF, Nath A, et al. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 2000;879:42-49
25. Nosheny RL, Bachis A, Acquas E, et al. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neuro-trophic factor in vivo: Potential implication for neuronal cell death. Eur J Neurosci 2004;20:2857-2864
26. Gorny MK, Xu JY, Gianakakos V, et al. Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci U S A 1991;88:3238-3242
27. Strayer DS. Gene therapy using SV40-derived vectors: What does the future hold? J Cell Physiol 1999;181:375-384
28. McKee HJ, Strayer DS. Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector. Vaccine 2002;20:3613-3625
29. Strayer DS, Kondo R, Milano J, et al. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells. Gene Ther 1997;4:219-225
30. Strayer DS, Lamothe M, Wei D, et al. Generation of recombinant SV40 vectors for gene transfer. SV40 protocols. In: Raptis L, ed. Methods in Molecular Biology. Totowa, NJ: Humana, 2001;165:103-117
31. Sauter BV, Parashar B, Chowdhury NR, et al. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in Gunn rats. Gastroenterology 2000;119:1348-1357
32. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. New York, NY: Academic Press, 1986
33. Rouger K, Louboutin JP, Villanova M, et al. X-linked vacuolated myopathy: TNF-alpha and IFN-gamma expression in muscle fibers with MHC class I on sarcolemma. Am J Pathol 2001;158:355-359
34. Wu CC, Reilly JF, Young WG, et al. High throughput morphometric analysis of individual neurons. Cereb Cortex 2004;14:543-554
35. Nikonov AA, Finger TE, Caprio J. Beyond the olfactory bulb: An odo-topic map in the forebrain. Proc Natl Acad Sci U S A 2005;102:18688-18693
36. Bigini P, Gardoni F, Barbera S, et al. Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice. BMC Neurosci 2006;7:71
37. Louboutin JP, Liu B, Reyes BAS, et al. Rat bone marrow progenitor cells transduced in situ by rSV40 vectors differentiate into multiple central nervous system lineages. Stem Cells 2006;24:2801-2809
38. Louboutin JP, Reyes BAS, Agrawal L, et al. Strategies for CNS-directed gene delivery: In vivo gene transfer to the brain using SV40-derived vectors. Gene Ther 2007;14:939-949
39. Mandel RJ, Rendahl KG, Spratt SK, et al. Characterization of intra-striatal recombinant adeno-associated virusYmediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's discase. J Neurosci. 1998;18:4271-4284.
40. Garden GA, Budd SL, Tsai E, et al. Caspase cascades in human immunodeficiency virusYassociated neurodegeneration. J Neurosci 2002; 22:4015-4024
41. Singh IN, Goody RJ, Dean C, et al. Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G. J Neurovirol 2004; 10:141-151
42. Turchan J, Pocernich CB, Gairola C, et al. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 2003;60:307-314
43. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128
44. Bao F, Dewitt DS, Prough DS, et al. Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: Reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J Neurosci Res 2003;71: 220-227
45. Annunziata P. Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism. J Neurol 2003;250:901-986
46. Berger JR, Avison M. The blood brain barrier in HIV infection. Front Biosci 2004;9:2680-2685
47. Bonde S, Ekdahl CT, Lindvall O. Long-term neuronal replacement in adult rat hippocampus after status epilepticus despite chronic inflammation. Eur J Neurosci 2006;23:965-974
48. Gelbard HA, James HJ, Sharer LR, et al. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol 1995;21:208-217
49. Twu C, Liu NQ, Popik W, et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion-and death receptorYcontrolled pathways. Proc Natl Acad Sci U S A 2002;99:14386-14391
50. Cicala C, Arthos J, Rubbert A, et al. HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. Proc Natl Acad Sci U S A 2000;97:1178-1183
51. Garden GA, Guo W, Jayadev S, et al. HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J 2004;18:1141-1143
52. Xu Y, Kulkosky J, Acheampong E, et al. HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1Yinduced encephalopathy. Proc Natl Acad Sci U S A 2004;101:7070-7075
53. Meucci O, Fatatis A, Simen AA, et al. Chemokines regulate hippo-campal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 1998;95:14500-14505
54. Kruman I, Nath A, Mattson MP. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 1998;154:276-288
55. Kaul M, Lipton SA. Chemokines and activated macrophages in HIV gp120Yinduced neuronal apoptosis. Proc Natl Acad Sci U S A 1999;96: 8212-8216
56. Cutler RG, Haughey NJ, Tammara A, et al. Dysregulation of sphingolipids and sterol metabolism by ApoE4 in HIV dementia. Neurology 2004;63:626-630
57. Kruman I, Bruce-Keller AJ, Bredesen D, et al. Evidence that 4-hydroxynonenal mediates oxidative stressYinduced neuronal apopto-sis. J Neurosci 1997;17:5089-5100
58. Bruce-Keller AJ, Li YJ, Lovell MA, et al. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol 1998;57:257-267
59. Sacktor N, Haughey N, Cutler R, et al. Novel markers of oxidative stress in actively progressive HIV dementia. J Neuroimmunol 2004;157: 176-184
60. Foga IO, Nath A, Hasinoff BB, et al. Antioxidants and dipyridamole inhibits HIV-1 gp120Yinduced free radicalYbased oxidative damage to human monocytoid cells. J Acquir Immune Defic Syndr 1997;16: 223-229
61. Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992;32:658-666
62. Power C, Kong PA, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann Neurol 1993;34:339-350
63. Avison MJ, Nath A, Greene-Avison R, et al. Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol 2004;157:140-146
64. Dallasta LM, Pisarov LA, Esplen JE, et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999;155:1915-1927
65. Finco O, Nuti S, De Magistris MT, et al. Induction of CD4+ T cell depletion in mice doubly transgenic for HIV gp120 and human CD4. Eur J Immunol 1997;27:1319-1324
66. Toneatto S, Finco O, van der Putten H, et al. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 1999;13:2343-2348
67. Liebetrau M, Holtmannspotter M, Arbusow V, Hamann GF. HIV-associated multiple intracerebral hemorrhages. Eur Neurol 2005;53: 100-102
68. Ake JA, Erickson JC, Lowry K. Cerebral aneurysmal arteriopathy associated with HIV infection in an adult. Clin Infect Dis 2006;43:46-50
69. Miyamoto S, Hara T, Tabei Y, et al. Aneurysmal subarachnoid hemorrhage in a patient with human deficiency virus type 1 infection. Case report. Neurol Med Chir (Tokyo) 2006;46:348-352
70. Hamilton DK, Kassell NF, Jensen ME, et al. Subarachnoid hemorrhage and diffuse vasculopathy in an adult infected with HIV. Case report. J Neurosurg 2007;106: 478-480
71. Tipping B, de Villiers L, Wainwright H, et al. Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry 2007;78:1320-1324
72. Modi G, Ranchod K, Modi M, et al. Human immunodeficiency virus associated intracranial aneurysms: Report of three adult patients with an overview of the literature. J Neurol Neurosurg Psychiatry 2008;79:44-46
73. Mazzoni P, Chiriboga CA, Millar WS, et al. Intracerebral aneurysms in human immunodeficiency virus infection: Case report and literature review. Pediatr Neurol 2000;23:252-255
74. Martinez-Longoria CA, Morales-Aguirre JJ, Villalobos-Acosta CP, et al. Occurrence of intracerebral aneurysm in an HIV-infected child. A case report. Pediatr Neurol 2004;31:130-132
75. Watanabe Y, Chu Y, Andresen JJ, et al. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003;34:434-440
76. Ridet JL, Bensadoun JC, Deglon N, et al. Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson's discase. J Neurosci. 2006;21:29-34.
77. Hoehn B, Yenari MA, Sapolsky RM, et al. Glutathione peroxidase overexpression inhibits cytochrome c release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 2003;34:2489-2494
78. Solbrig MV, Koob GF, Parsons LH, et al. Neurotrophic factor expression after CNS viral injury produces enhanced sensitivity to psychostimulants: Potential mechanisms for addiction vulnerability. J Neurosci 2000;20:RC104